JOINT DEVELOPMENT AND COMMERCIALIZATION AGREEMENT BY AND BETWEEN GTC BIOTHERAPEUTICS, INC. AND LFB-BIOTECHNOLOGIES S.A.S.U. September 29, 2006Joint Development and Commercialization Agreement • November 3rd, 2006 • GTC Biotherapeutics Inc • Biological products, (no disgnostic substances) • New York
This Joint Development and Commercialization Agreement (the “Agreement”) is entered into as of September 29, 2006 (the “Effective Date”), by and between GTC Biotherapeutics, Inc., a Massachusetts corporation, having offices at 175 Crossing Boulevard, Framingham, Massachusetts 01702, USA (“GTC”), and LFB Biotechnologies S.A.S.U., a société par actions simplifiée unipersonnelle, having offices at 3, avenue des Tropiques, Les Ulis, 91958 Courtaboeuf, France (“LFB Biotech”). GTC and LFB Biotech are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
